Olema Pharmaceuticals Inc
OLMA
Market Cap$384.19M
Close$
$2.35
49.7% downside
Current Fair Value
49.7% downsideOvervalued by 49.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $384.19 Million |
|---|---|
| Enterprise Value | $246.18 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2.2 |
| Beta | 2.11 |
| Outstanding Shares | 74,312,608 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.23 |
|---|---|
| PEG | -5.31 |
| Price to Sales | - |
| Price to Book Ratio | 0.93 |
| Enterprise Value to Revenue | 130.67 |
| Enterprise Value to EBIT | -1.81 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Olema Pharmaceuticals Inc
37 employeesOlema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of targeted therapies for women’s cancers. Its lead product candidate, OP-1250, is an o...